|
|
|
|
|
Last Trade
|
Last Trade:
$17.27
|
Change:
-0.01 (-0.06%)
|
Trade Time:
Jul 10
|
Market Cap:
$54.45B
|
|
|
|
|
|
|
Description of Business
|
|
We are a global, values-based, research and development ("R&D") driven
biopharmaceutical company with operations in approximately 80 countries. We
bring highly innovative, life changing medicines to patients across the globe,
with prescription drugs marketed directly or through our partners in
approximately 100 countries worldwide. Our global workforce is committed to
bringing better health and a brighter future to patients. We develop and market
pharmaceutical products in gastroenterology ("GI"), rare diseases including rare
metabolic, rare hematology and heredity angioedema, oncology, neuroscience, as
well as Plasma-Derived Therapies ("PDT") and vaccines. We are also committed to
our corporate social responsibility program, which is dedicated to global
health, and our access to medicine strategy, which aims to increase access to
innovative and potentially lifesaving medicines for patients with some of the
highest unmet medical needs across the world.
|
|
|
|